メインコンテンツに移動
翻訳中 — お使いの言語版を準備している間、このコンテンツは英語で表示されています。

Evolving Health and Wellbeing of Thalidomide Survivors as They Age

Healthcare
グローバル
September 17, 2026に開始

This scoping review updates the 2017 review by exploring evidence published 2017-2025 on the physical, mental, and social wellbeing of ageing thalidomide survivors, identifying emerging health issues, care needs, and evidence gaps

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 投票すべき主張 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 投稿者: admin Sep 17, 2026
Evidence on the long-term health trajectories of thalidomide survivors must be systematically gathered and shared with clinicians treating this aging population.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Survivors' lived experience and self-reported health concerns should shape research priorities as much as clinical datasets.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Surviving thalidomide exposure does not automatically increase risk of age-related disease beyond the general population.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
The government must implement policies that ensure comprehensive support for the aging population of thalidomide survivors.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
The current healthcare system fails to adequately support the evolving needs of thalidomide survivors as they age.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Thalidomide survivors do not need special considerations in healthcare beyond what is offered to other aging populations.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Cross-national data on thalidomide survivor aging outcomes is fragmented and should be pooled into a coordinated international registry.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Thalidomide survivors should have prioritized access to mental health services as they age.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
The unique needs of thalidomide survivors should be integrated into mainstream aging and disability policies.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin Sep 17, 2026
Whether survivors receive compensation or not, healthcare systems must prepare now for emerging age-related conditions unique to this cohort.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us